Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationBone MarrowBone Marrow TransplantationBone Marrow CellsTransplantation, HomologousPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanTransplantation ConditioningCombined Modality TherapyTreatment OutcomeBone and BonesStem CellsRemission InductionBone Marrow PurgingSalvage TherapyHematopoietic Stem CellsCyclophosphamideDisease-Free SurvivalEtoposideGraft vs Host DiseaseHodgkin DiseaseLymphoma, Non-HodgkinRecurrenceCytarabineMyeloablative AgonistsHematopoietic Stem Cell MobilizationCarmustineWhole-Body IrradiationSurvival RateVincristineThiotepaHematologic NeoplasmsSurvival AnalysisBusulfanAntigens, CD34Retrospective StudiesGraft SurvivalLymphoma, Mantle-CellPrognosisDoxorubicinAmyloidosisBone Marrow DiseasesTime FactorsDexamethasoneBoronic AcidsFollow-Up StudiesPyrazinesGranulocyte Colony-Stimulating FactorBone RemodelingLymphoma, FollicularAntineoplastic Agents, AlkylatingTransplantation ChimeraAntibodies, Monoclonal, Murine-DerivedBone Marrow ExaminationHematopoiesisMesenchymal Stem Cell TransplantationLymphoma, T-Cell, PeripheralAntineoplastic AgentsCell DifferentiationLeukemia, Myeloid, AcuteLymphomaAutograftsThalidomideBone Marrow NeoplasmsLiver TransplantationIfosfamideTissue DonorsPrednisoneNeoplasm, ResidualLeukapheresisMyelodysplastic SyndromesInduction ChemotherapyPodophyllotoxinLeukemiaLymphoma, Large B-Cell, DiffuseCells, CulturedBone DensityCord Blood Stem Cell TransplantationCell TransplantationMaintenance ChemotherapyAntibodies, MonoclonalLeukemia, MyeloidMice, Inbred C57BLFlow CytometryHistocompatibility TestingLymphoma, B-CellBone NeoplasmsMesenchymal Stromal CellsImmunosuppressive AgentsT-LymphocytesProspective StudiesBone ResorptionKidney TransplantationMitoxantroneEmbryonic Stem CellsColony-Forming Units Assay